The PKCβ-mediated activation and phosphorylation of p110γ constitutes therefore an unprecedented PI3K molecular switch, which enables the operation of p110γ downstream of FcεRI signaling, and will elucidate cell type-specific activation processes in allergy and chronic inflammation. The gene discussed is PRKCB; the disease is Allergy.